Loading...
Gerresheimer AG
GRRMF•PNK
Healthcare
Medical - Instruments & Supplies
$46.70
$-5.08(-9.81%)
Gerresheimer AG (GRRMF) Financial Performance & Income Statement Overview
Review Gerresheimer AG’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
2.28%
↑ 2.28%
Operating Income Growth
-7.46%
↓ 7.46%
Net Income Growth
-5.52%
↓ 5.52%
Operating Cash Flow Growth
-18.35%
↓ 18.35%
Operating Margin
8.82%
↑ 8.82%
Gross Margin
28.95%
↑ 28.95%
Net Profit Margin
3.77%
↑ 3.77%
ROE
5.30%
↑ 5.30%
ROIC
6.29%
↑ 6.29%
Gerresheimer AG (GRRMF) Income Statement & Financial Overview
Review Gerresheimer AG's (GRRMF) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $520.05M | $568.87M | $498.51M | $502.38M |
| Cost of Revenue | $393.30M | $387.19M | $350.68M | $353.72M |
| Gross Profit | $126.75M | $181.68M | $147.84M | $148.66M |
| Gross Profit Ratio | $0.24 | $0.32 | $0.30 | $0.30 |
| R&D Expenses | $6.12M | $6.89M | $4.77M | $5.15M |
| SG&A Expenses | $103.17M | $60.16M | $95.08M | $84.16M |
| Operating Expenses | $111.63M | $120.12M | $90.05M | $89.31M |
| Total Costs & Expenses | $504.94M | $507.31M | $450.13M | $443.04M |
| Interest Income | $1.27M | $2.09M | $809000.00 | $1.05M |
| Interest Expense | $42.53M | $17.46M | $15.46M | $14.30M |
| Depreciation & Amortization | $67.19M | $52.02M | $50.42M | $37.98M |
| EBITDA | $84.40M | $117.06M | $101.03M | $106.71M |
| EBITDA Ratio | $0.16 | $0.21 | $0.20 | $0.21 |
| Operating Income | $15.12M | $61.56M | $48.38M | $55.64M |
| Operating Income Ratio | $0.03 | $0.11 | $0.10 | $0.11 |
| Other Income/Expenses (Net) | -$40.44M | -$13.98M | -$13.23M | -$11.90M |
| Income Before Tax | -$25.32M | $47.58M | $35.15M | $43.74M |
| Income Before Tax Ratio | -$0.05 | $0.08 | $0.07 | $0.09 |
| Income Tax Expense | -$7.83M | $9.29M | $7.49M | $10.80M |
| Net Income | -$18.01M | $37.04M | $27.21M | $32.46M |
| Net Income Ratio | -$0.03 | $0.07 | $0.05 | $0.06 |
| EPS | -$0.52 | $1.07 | $0.79 | $0.94 |
| Diluted EPS | -$0.52 | $1.07 | $0.79 | $0.94 |
| Weighted Avg Shares Outstanding | $34.54M | $34.54M | $34.54M | $34.54M |
| Weighted Avg Shares Outstanding (Diluted) | $34.54M | $34.54M | $34.54M | $34.54M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan